Evidence map›Paper›PMID 22013221›Full record

ArticleThe Journal of infectious diseases2011

Evaluation of monkeypox disease progression by molecular imaging.

Julie Dyall, Reed F Johnson, Dar-Yeong Chen, Louis Huzella, Dan R Ragland, Daniel J Mollura, Russell Byrum, Richard C Reba, Gerald Jennings, Peter B Jahrling and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Validation of Lung [Molecular imaging and biology · 2025
    Article
  3. Review
  4. Review
  5. Poxviridae Pneumonia.Advances in experimental medicine and biology · 2024
    Review
  6. Review
  7. Review
  8. First [18F]-FDG-PET/CT images of a patient infected with Monkeypox.European journal of nuclear medicine and molecular imaging · 2023
    Article
  9. Monkeypox Virus Infections in Humans.Clinical microbiology reviews · 2022
    Review
  10. Preclinical evaluation of [European journal of nuclear medicine and molecular imaging · 2022
    Article
  11. Monkeypox virus crosstalk with HIV; where do we stand now?International journal of surgery (London, England) · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. [Journal of virology · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Julie DyallIntegrated Research Facility, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Reed F Johnson
Dar-Yeong Chen
Louis Huzella
Dan R Ragland
Daniel J Mollura
Russell Byrum
Richard C Reba
Gerald Jennings
Peter B Jahrling
Joseph E Blaney
Jason Paragas
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health Clinical Center · US

Funding

Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERSZIAAI001025 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI JOHNSON, REED · 2009 to 2018
$14.1M
Intramural NIH HHSPHS HHS HHSN272200200016I
6 · The paper itself

Abstract

Infection of nonhuman primates (NHPs) with monkeypox virus (MPXV) is currently being developed as an animal model of variola infection in humans. We used positron emission tomography and computed tomography (PET/CT) to identify inflammatory patterns as predictors for the outcome of MPXV disease in NHPs. Two NHPs were sublethally inoculated by the intravenous (IV) or intrabronchial (IB) routes and imaged sequentially using fluorine-18 fluorodeoxyglucose ((18)FDG) uptake as a nonspecific marker of inflammation/immune activation. Inflammation was observed in the lungs of IB-infected NHPs, and bilobular involvement was associated with morbidity. Lymphadenopathy and immune activation in the axillary lymph nodes were evident in IV- and IB-infected NHPs. Interestingly, the surviving NHPs had significant (18)FDG uptake in the axillary lymph nodes at the time of MPXV challenge with no clinical signs of illness, suggesting an association between preexisting immune activation and survival. Molecular imaging identified patterns of inflammation/immune activation that may allow risk assessment of monkeypox disease.

Indexed as

Disease ProgressionMultimodal ImagingPositron-Emission TomographyTomography, X-Ray ComputedAnimalsAxillaBronchiDisease Models, AnimalFemaleFluorodeoxyglucose F18Injections, IntravenousLungLymph NodesMacaca fascicularisMaleMonkeypox virusFluorodeoxyglucose F18

Identifiers

PMID22013221
PMCPMC3209815
OpenAlexW2143655109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.